Genmab A/S GNMSF
541.00 USD -5.00 (-0.92%)
At closeNov 10, 2026, 4:00 PM EST
535.00 Day range 541.00
232.34 52-week range 581.00
- YTD
- +72.29%
- 1 year
- +86.22%
News
seekingalpha.com Genmab A/S (GMAB) Q1 2026 Earnings Call Transcript Genmab A/S (GMAB) Q1 2026 Earnings Call Transcript
defenseworld.net Genmab A/S (OTCMKTS:GNMSF) Stock Price Crosses Below 200 Day Moving Average – Here’s Why Genmab A/S (OTCMKTS:GNMSF - Get Free Report)'s stock price crossed below its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $305.26 and traded as low as…
seekingalpha.com Genmab A/S (GMAB) Presents at Barclays 28th Annual Global Healthcare Conference Transcript Genmab A/S (GMAB) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
seekingalpha.com Genmab A/S (GMAB) Q4 2025 Earnings Call Transcript Genmab A/S (GMAB) Q4 2025 Earnings Call Transcript
seekingalpha.com Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance From a sector perspective, strength within Industrials and Information Technology offset relative weakness in Health Care. The October earnings report reinforced confidence in Comfort Systems'…
seekingalpha.com Genmab A/S (GMAB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Genmab A/S (GMAB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
seekingalpha.com Genmab A/S (GMAB) Discusses 2025 R&D Progress, ASH Data Review, and Strategic Pipeline Additions Transcript Genmab A/S (GMAB) Discusses 2025 R&D Progress, ASH Data Review, and Strategic Pipeline Additions Transcript
seekingalpha.com Genmab A/S (GMAB) Presents at Citi Annual Global Healthcare Conference 2025 Transcript Genmab A/S (GMAB) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
seekingalpha.com Genmab A/S (GMAB) Presents at Jefferies London Healthcare Conference 2025 Transcript Genmab A/S (GMAB) Jefferies London Healthcare Conference 2025 November 19, 2025 7:00 AM EST Company Participants Jan van de Winkel - Co-Founder, President & CEO Anthony Pagano - Executive VP & CFO…
seekingalpha.com Genmab A/S (GMAB) Q3 2025 Earnings Call Transcript Genmab A/S (GMAB) Q3 2025 Earnings Call November 6, 2025 12:00 PM EST Company Participants Jan van de Winkel - Co-Founder, President & CEO Tahamtan Ahmadi - Executive VP, Chief Medical Officer & Head…
seekingalpha.com Genmab A/S (GMAB) M&A Call Transcript Genmab A/S (GMAB) M&A Call September 29, 2025 7:00 AM EDT Company Participants Jan van de Winkel - Co-Founder, President & CEO Tahamtan Ahmadi - Executive VP, Chief Medical Officer & Head of…
seekingalpha.com Genmab A/S (GMAB) Presents at Bank of America Global Healthcare Conference 2025 Transcript Genmab A/S (GMAB) Bank of America Global Healthcare Conference 2025 September 23, 2025 6:35 AM EDT Company Participants Anthony Pagano - Executive VP & CFO Conference Call Participants Sachin Jain -…
seekingalpha.com Genmab A/S (GMAB) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript Genmab A/S (GMAB) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 7:45 AM EDT Company Participants Jan van de Winkel - Co-Founder, President & CEO Anthony Pagano - Executive…
seekingalpha.com Genmab A/S (GMAB) Q2 2025 Earnings Call Transcript Genmab A/S (GMAB) Q2 2025 Earnings Conference Call August 7, 2025 12:00 PM ET Company Participants Anthony Pagano - Executive VP & CFO Brad Bailey - Corporate Participant Jan G.J. van de Winkel -…
seekingalpha.com Genmab A/S (GMAB) Q4 2024 Earnings Conference Call Transcript Genmab A/S (GMAB) Q4 2024 Earnings Conference Call February 12, 2025 12:00 PM ET Company Participants Jan van de Winkel - CEO Brad Bailey - EVP and Chief Commercial Officer Anthony Pagano - CFO…
seekingalpha.com Genmab A/S (GMAB) Q3 2024 Earnings Conference Call Transcript Genmab A/S (GMAB) Q3 2024 Earnings Conference Call November 6, 2024 12:00 PM ET Company Participants Jan van de Winkel - CEO Brad Bailey - EVP and Chief Commercial Officer Anthony Pagano - CFO Judith…
globenewswire.com Grant of Restricted Stock Units and Warrants to Employees in Genmab Company Announcement COPENHAGEN, Denmark; September 26, 2024 – Genmab A/S (Nasdaq: GMAB) announced today that the Board decided to grant 23,954 restricted stock units and 13,915 warrants to employees…
globenewswire.com Capital Increase in Genmab as a Result of Employee Warrant Exercise Company Announcement COPENHAGEN, Denmark; September 10, 2024 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 11,729 shares as a consequence of the exercise of employee warrants. The…
globenewswire.com Genmab to Present at Morgan Stanley 22nd Annual Global Healthcare Conference Media Release COPENHAGEN, Denmark; August 26, 2024 Genmab A/S (Nasdaq: GMAB ) a nnounced today that its Chief Executive Officer Jan van de Winkel, Ph.D. and Chief Financial Officer Anthony Pagano…
seekingalpha.com Genmab: Strong H1 2024 Performance, Partner BioNTech Gives Up On Acasunlimab Genmab's stock continues to struggle despite the strong progress of the company's commercial portfolio in the first half of the year. Epkinly is now FDA-approved for third-line+ follicular lymphoma,…
benzinga.com Stocks That Hit 52-Week Highs On Tuesday 
benzinga.com Stocks That Hit 52-Week Highs Of Tuesday